Annual CFF
$9000.00
+$8000.00+800.00%
December 31, 2023
Summary
- As of February 7, 2025, ACHL annual cash flow from financing activities is $9000.00, with the most recent change of +$8000.00 (+800.00%) on December 31, 2023.
- During the last 3 years, ACHL annual CFF has fallen by -$113.69 million (-99.99%).
- ACHL annual CFF is now -99.99% below its all-time high of $160.75 million, reached on December 31, 2021.
Performance
ACHL Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
N/A
September 1, 2024
Summary
- ACHL quarterly cash flow from financing activities is not available.
Performance
ACHL Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
N/A
September 1, 2024
Summary
- ACHL TTM cash flow from financing activities is not available.
Performance
ACHL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ACHL Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +800.0% | - | - |
| 3 y3 years | -100.0% | - | - |
| 5 y5 years | -100.0% | - | - |
ACHL Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | +800.0% | ||||
| 5 y | 5-year | -100.0% | +800.0% | ||||
| alltime | all time | -100.0% | +800.0% |
Achilles Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $5000.00(+400.0%) | $5000.00(+150.0%) |
| Dec 2023 | $9000.00(+800.0%) | - | - |
| Mar 2023 | - | $1000.00(>+9900.0%) | $2000.00(+100.0%) |
| Dec 2022 | $1000.00(-100.0%) | $0.00(-100.0%) | $1000.00(0.0%) |
| Sep 2022 | - | $1000.00(>+9900.0%) | $1000.00(-98.3%) |
| Jun 2022 | - | $0.00(0.0%) | $60.00 K(-100.0%) |
| Mar 2022 | - | $0.00(0.0%) | $161.67 M(+0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $160.75 M(+41.4%) | $0.00(-100.0%) | $160.75 M(0.0%) |
| Sep 2021 | - | $60.00 K(-100.0%) | $160.75 M(+0.0%) |
| Jun 2021 | - | $161.61 M(<-9900.0%) | $160.69 M(<-9900.0%) |
| Mar 2021 | - | -$914.00 K(+366.3%) | -$914.00 K(+366.3%) |
| Dec 2020 | $113.70 M(+21.5%) | - | - |
| Mar 2020 | - | -$196.00 K | -$196.00 K |
| Dec 2019 | $93.62 M | - | - |
FAQ
- What is Achilles Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Achilles Therapeutics?
- What is Achilles Therapeutics annual CFF year-on-year change?
- What is the all time high quarterly CFF for Achilles Therapeutics?
- What is the all time high TTM CFF for Achilles Therapeutics?
What is Achilles Therapeutics annual cash flow from financing activities?
The current annual CFF of ACHL is $9000.00
What is the all time high annual CFF for Achilles Therapeutics?
Achilles Therapeutics all-time high annual cash flow from financing activities is $160.75 M
What is Achilles Therapeutics annual CFF year-on-year change?
Over the past year, ACHL annual cash flow from financing activities has changed by +$8000.00 (+800.00%)
What is the all time high quarterly CFF for Achilles Therapeutics?
Achilles Therapeutics all-time high quarterly cash flow from financing activities is $161.61 M
What is the all time high TTM CFF for Achilles Therapeutics?
Achilles Therapeutics all-time high TTM cash flow from financing activities is $161.67 M